These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38625730)

  • 21. Randomized, double-blind, placebo-controlled study of XP13512/GSK1838262 in patients with RLS.
    Kushida CA; Becker PM; Ellenbogen AL; Canafax DM; Barrett RW;
    Neurology; 2009 Feb; 72(5):439-46. PubMed ID: 19188575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Gabapentin Enacarbil on Individual Items of the International Restless Legs Study Group Rating Scale and Post-sleep Questionnaire in Adults with Moderate-to-Severe Primary Restless Legs Syndrome: Pooled Analysis of 3 Randomized Trials.
    Ahmed M; Hays R; Steven Poceta J; Jaros MJ; Kim R; Shang G
    Clin Ther; 2016 Jul; 38(7):1726-1737.e1. PubMed ID: 27288210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rotigotine in Hemodialysis-Associated Restless Legs Syndrome: A Randomized Controlled Trial.
    Dauvilliers Y; Benes H; Partinen M; Rauta V; Rifkin D; Dohin E; Goldammer N; Schollmayer E; Schröder H; Winkelman JW
    Am J Kidney Dis; 2016 Sep; 68(3):434-43. PubMed ID: 26851201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of restless legs syndrome with pregabalin: a double-blind, placebo-controlled study.
    Garcia-Borreguero D; Larrosa O; Williams AM; Albares J; Pascual M; Palacios JC; Fernandez C
    Neurology; 2010 Jun; 74(23):1897-904. PubMed ID: 20427750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical efficacy and safety of IV ferric carboxymaltose in restless legs syndrome: A meta-analysis of 537 patients.
    Qadri SN; Jamil S; Zahid S; Asghar T; Gillani SM; Qasim SA; Kambar T; Abideen ZU; Brohi U; Tareen SK; Tareen PK; Kumari S; Kumar S; Khatri M
    Sleep Med; 2024 Sep; 124():244-253. PubMed ID: 39326219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics, safety and tolerability of intravenous ferric carboxymaltose: a dose-escalation study in volunteers with mild iron-deficiency anaemia.
    Geisser P; Banké-Bochita J
    Arzneimittelforschung; 2010; 60(6a):362-72. PubMed ID: 20648928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study.
    Walters AS; Ondo WG; Dreykluft T; Grunstein R; Lee D; Sethi K;
    Mov Disord; 2004 Dec; 19(12):1414-23. PubMed ID: 15390050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gabapentin enacarbil in Japanese patients with restless legs syndrome: a 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Inoue Y; Hirata K; Uchimura N; Kuroda K; Hattori N; Takeuchi M
    Curr Med Res Opin; 2013 Jan; 29(1):13-21. PubMed ID: 23121149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries.
    Trenkwalder C; Garcia-Borreguero D; Montagna P; Lainey E; de Weerd AW; Tidswell P; Saletu-Zyhlarz G; Telstad W; Ferini-Strambi L;
    J Neurol Neurosurg Psychiatry; 2004 Jan; 75(1):92-7. PubMed ID: 14707315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of Intravenous Iron Sucrose in Hemodialysis Patients with Restless Legs Syndrome (RLS): A Randomized, Placebo-Controlled Study.
    Deng Y; Wu J; Jia Q
    Med Sci Monit; 2017 Mar; 23():1254-1260. PubMed ID: 28285317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ropinirole in the treatment of patients with restless legs syndrome: a US-based randomized, double-blind, placebo-controlled clinical trial.
    Bogan RK; Fry JM; Schmidt MH; Carson SW; Ritchie SY;
    Mayo Clin Proc; 2006 Jan; 81(1):17-27. PubMed ID: 16438474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a single dose of ferric carboxymaltose in fatigued, iron-deficient women--PREFER a randomized, placebo-controlled study.
    Favrat B; Balck K; Breymann C; Hedenus M; Keller T; Mezzacasa A; Gasche C
    PLoS One; 2014; 9(4):e94217. PubMed ID: 24751822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: A randomized, placebo-controlled study (IRON-CLAD).
    Makharadze T; Boccia R; Krupa A; Blackman N; Henry DH; Gilreath JA
    Am J Hematol; 2021 Dec; 96(12):1639-1646. PubMed ID: 34653287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of pramipexole in restless legs syndrome: a six-week, multicenter, randomized, double-blind study (effect-RLS study).
    Oertel WH; Stiasny-Kolster K; Bergtholdt B; Hallström Y; Albo J; Leissner L; Schindler T; Koester J; Reess J;
    Mov Disord; 2007 Jan; 22(2):213-9. PubMed ID: 17133582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial.
    Ponikowski P; Kirwan BA; Anker SD; McDonagh T; Dorobantu M; Drozdz J; Fabien V; Filippatos G; Göhring UM; Keren A; Khintibidze I; Kragten H; Martinez FA; Metra M; Milicic D; Nicolau JC; Ohlsson M; Parkhomenko A; Pascual-Figal DA; Ruschitzka F; Sim D; Skouri H; van der Meer P; Lewis BS; Comin-Colet J; von Haehling S; Cohen-Solal A; Danchin N; Doehner W; Dargie HJ; Motro M; Butler J; Friede T; Jensen KH; Pocock S; Jankowska EA;
    Lancet; 2020 Dec; 396(10266):1895-1904. PubMed ID: 33197395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment response to sleep, pain, and mood disturbance and their correlation with sleep disturbance in adult patients with moderate-to-severe primary restless legs syndrome: Pooled analyses from 3 trials of gabapentin enacarbil.
    Bogan RK; Lee DO; Buchfuhrer MJ; Jaros MJ; Kim R; Shang G
    Ann Med; 2015 May; 47(3):269-77. PubMed ID: 25874578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does Repeated Dosing of Intravenous Ferric Carboxymaltose Alleviate Symptoms of Restless Legs Syndrome?
    Park HR; Choi SJ; Joo EY
    J Clin Med; 2022 Mar; 11(6):. PubMed ID: 35329998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of clinical response in a double-blind placebo controlled crossover trial of gabapentin enacarbil for restless legs syndrome.
    Winkelman JW; Jaros MJ
    Sleep Med; 2018 Aug; 48():1-7. PubMed ID: 29807228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, double-blind, placebo controlled, multi-center study of intravenous iron sucrose and placebo in the treatment of restless legs syndrome.
    Grote L; Leissner L; Hedner J; Ulfberg J
    Mov Disord; 2009 Jul; 24(10):1445-52. PubMed ID: 19489063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial.
    Trenkwalder C; Benes H; Poewe W; Oertel WH; Garcia-Borreguero D; de Weerd AW; Ferini-Strambi L; Montagna P; Odin P; Stiasny-Kolster K; Högl B; Chaudhuri KR; Partinen M; Schollmayer E; Kohnen R;
    Lancet Neurol; 2008 Jul; 7(7):595-604. PubMed ID: 18515185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.